30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Bioventus Secures BCBS Coverage for OA Treatments -

Bioventus secured preferred access for Blue Cross Blue Shield of Michigan Medicare Advantage and Commercial patients to DUROLANE, GELSYN-3 and SUPARTZ FX to treat knee osteoarthritis pain, active in 2020. DUROLANE, is a single-injection, GELSYN-3, a three-injection and SUPARTZ FX, a five-injection hyaluronic acid (HA)-based joint-fluid treatment. The products are among the four preferred choices for HA coverage under the medical benefit for PPO, HMO, Medicare Plus Blue PPO and BCN Advantage plans.